Stock listing

Dusseldorf:BKD Bruker Corporation Aktie

German listing (Dusseldorf) of Bruker Corporation · home listing NASDAQ:BRKR

Follow Bruker Corporation into a list and get an email when it puts out news.

Home listing price · NASDAQ:BRKR

$56.46 USD -6.80 (-10.7%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BRKR

Past year +28.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$56.13 – $61.10 USDNov 20, 2026
Volume
2.25M sharesNov 20, 2026
Market cap
$8.62B USDAt the close on Nov 20, 2026 · price × 152.7M shares outstanding
52-week range
$32.37 – $68.98 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$138.5M USDMedian day 2.17M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Bruker Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BRKR · Home$56.46 USD-6.80 (-10.7%)2,250,882$60.65$61.10$56.13$63.26Close on Nov 20, 2026
Frankfurt:BKD€55.68 EUR-2.64 (-4.5%)—€55.59€55.68€55.59€58.32Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BRKR · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$56.46-6.80-10.7%$60.65$61.10$56.132,250,882
$63.26+1.90+3.1%$61.09$64.61$61.011,726,086
$61.36+0.74+1.2%$60.38$62.22$60.031,875,188
$60.62-0.97-1.6%$60.52$61.81$59.502,645,306
$61.59+1.26+2.1%$60.36$61.94$59.132,021,022
$60.33-2.08-3.3%$60.22$61.40$58.681,510,997
$62.41+0.17+0.3%$62.90$64.28$61.962,467,724
$62.24-4.30-6.5%$66.51$66.51$62.132,884,198
$66.54+5.23+8.5%$62.30$67.05$61.702,857,908
$61.31+3.25+5.6%$59.00$61.66$58.462,012,689
$58.06-5.73-9.0%$61.94$62.33$57.863,262,133
$63.79+7.29+12.9%$65.39$68.98$59.137,408,351
$56.50+0.81+1.5%$57.07$59.38$55.804,339,422
$55.69-1.38-2.4%$57.07$57.20$55.151,894,471
$57.07-4.93-8.0%$59.47$60.17$56.001,921,320
$62.000.000.0%$61.18$62.52$61.001,501,991
$62.00+1.26+2.1%$60.66$63.39$60.552,981,331
$60.74+2.51+4.3%$58.43$61.00$57.752,290,605
$58.23+0.64+1.1%$57.79$58.30$57.282,329,686
$57.59+0.28+0.5%$56.93$57.78$55.321,219,702
$57.31-1.795-3.0%$59.11$60.67$55.522,371,664
$59.11+3.175+5.7%$55.42$59.49$55.423,561,058
$55.93+0.56+1.0%$55.52$56.94$54.851,567,468
$55.37+0.57+1.0%$54.89$56.20$54.681,911,875
$54.80-1.74-3.1%$56.45$57.18$54.271,674,200
$56.54+0.94+1.7%$54.97$57.01$54.442,106,400
$55.60-0.59-1.1%$55.39$58.08$54.572,335,500
$56.19-0.06-0.1%$55.64$56.67$54.832,171,600
$56.25-2.59-4.4%$58.75$58.75$55.891,863,000
$58.84+0.92+1.6%$57.92$59.56$57.561,465,500
$57.92-1.80-3.0%$59.23$59.23$56.292,556,000
$59.72-0.78-1.3%$60.85$61.38$57.332,907,800
$60.50-3.36-5.3%$64.67$66.42$59.302,903,800
$63.86+0.62+1.0%$63.12$64.48$62.652,015,900
$63.24+1.30+2.1%$62.25$64.36$62.252,227,600
$61.94-2.81-4.3%$64.30$64.82$61.702,378,100
$64.75+0.24+0.4%$64.32$66.98$63.862,138,900
$64.51+1.23+1.9%$63.61$64.79$62.441,745,000
$63.28-0.90-1.4%$63.22$64.95$62.372,612,700
$64.18+0.18+0.3%$64.33$65.26$62.382,525,600
$64.00+4.33+7.3%$59.17$65.00$59.172,256,900
$59.67-1.54-2.5%$60.70$62.59$59.372,498,600
$61.21-0.37-0.6%$62.29$62.47$60.911,981,500
$61.58+0.19+0.3%$62.05$62.67$60.571,597,500
$61.39-1.66-2.6%$63.37$63.49$60.402,820,300
$63.05+2.38+3.9%$61.90$64.42$61.303,075,000
$60.67+4.92+8.8%$56.64$61.72$56.614,105,800
$55.75+3.09+5.9%$52.87$56.34$52.863,010,300
$52.66-0.77-1.4%$53.11$53.62$51.542,784,900
$53.43-0.13-0.2%$53.77$54.33$53.082,091,300
$53.56-0.87-1.6%$53.21$54.31$52.581,882,900
$54.43-3.94-6.8%$57.93$58.01$53.462,959,900
$58.37-0.13-0.2%$57.58$58.57$56.801,040,700
$58.50-0.91-1.5%$59.32$59.79$58.261,334,200
$59.41+0.39+0.7%$59.82$60.29$57.471,208,600
$59.02+2.99+5.3%$56.03$59.25$56.031,899,500
$56.03-1.98-3.4%$57.79$58.00$55.662,028,200
$58.01+0.93+1.6%$57.18$58.36$56.031,859,800
$57.08-2.17-3.7%$58.68$59.21$56.851,928,400
$59.25+2.19+3.8%$58.13$59.52$57.612,433,400
$57.06+0.21+0.4%$56.26$57.56$56.262,528,300
$56.85-0.13-0.2%$57.38$58.19$56.001,626,200
$56.98-2.58-4.3%$59.01$59.11$56.901,174,200
$59.56-0.36-0.6%$59.60$60.31$58.063,199,900
$59.92+1.27+2.2%$57.07$61.41$57.071,414,800
Ticker
Dusseldorf:BKD
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Dusseldorf
Currency
EUR

What changed lately

Latest news

All Bruker Corporation news

Bruker Corporation on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
43 in the last 12 months · 271 in all · newest Nov 16, 2026 · oldest 2019
Calls
25 calls with a replay · 25 with a transcript · latest Nov 4, 2026
Decks
105 decks · latest Nov 4, 2026

Where Bruker Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:BRKR · Home listingNASDAQUnited StatesUSD
NASDAQ:BRKRPNASDAQUnited StatesUSD
gettex:BKDgettexGermanyEUR
Milan:1BRKRMilanItalyEUR
BMV:BRKRBMVMexicoMXN
LS Exchange:813534LS ExchangeGermanyEUR
B3:B2RK34B3BrazilBRL
Lang & Schwarz:813534Lang & SchwarzGermanyEUR
Tradegate:BKDTradegateGermanyEUR
BOATS:BRKRPBOATSUnited StatesUSD
Frankfurt:BKDFrankfurtGermanyEUR
Dusseldorf:BKD · This pageDusseldorfGermanyEUR
Hamburg:BKDHamburgGermanyEUR
BIVA:BRKRBIVAMexicoMXN
BOATS:BRKRBOATSUnited StatesUSD
Stuttgart:BKDStuttgartGermanyEUR
BX Swiss:BKDBX SwissSwitzerlandCHF
Hanover:BKDHanoverGermanyEUR
Xetra:BKDXetraGermanyEUR

Valuation

EV/sales 2.9× against a median of 5.6×: 3rd lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$10.22B USD
P/E
Loss
EV/sales
2.9×
EV/EBITDA
64.4×
Price/book
3.7×
Gross margin
47.7%
Operating margin
−2.0%
Net margin
−3.5%
Debt to equity
0.7×
Beta vs S&P 500
1.72

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Bruker Corporation · NASDAQ:BRKRUS$8.62BUS$10.22Bn/a2.9×64.4×3.7×−3.5%0.7×1.72
Qiagen N.V. · NYSE:QGENUS$10.18BUS$11.03B24.9×5.3×15.0×3.0×19.5%0.5×0.33
Avantor, Inc. · NYSE:AVTRUS$10.06BUS$13.28B29.8×2.0×14.7×1.7×5.1%0.6×0.78
WuXi XDC Cayman, Inc. · HKEX:2268US$9.64BUS$8.87B43.5×10.0×33.5×5.7×24.9%0.1×n/a
Tempus AI, Inc. · NASDAQ:TEMUS$9.58BUS$8.99Bn/a6.0×n/a19.1×−12.5%0.0×2.51
Pharmaron Beijing Co., Ltd. Class A · SZSE:300759US$8.52BUS$8.23B32.1×3.4×n/a3.4×11.1%0.1×n/a
GenScript Biotech Corporation · HKEX:1548US$8.08BUS$7.50Bn/a7.8×22.8×2.1×−55.5%0.1×n/a
Bio-Rad Laboratories, Inc. · NYSE:BIOUS$7.84BUS$7.38B7.7×2.8×71.0×1.0×39.5%0.2×0.72
Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A · SZSE:300832US$7.51BUS$7.10B27.8×9.8×n/a5.3×37.2%0.0×n/a
Twist Bioscience Corporation · NASDAQ:TWSTUS$7.04BUS$6.46Bn/a14.1×n/a7.9×−28.3%0.0×2.77
Asymchem Laboratories (Tianjin) Co., Ltd. Class A · SZSE:002821US$6.83BUS$5.89B38.5×5.3×n/a2.6×15.9%0.0×n/a
Median of the othersUS$8.30BUS$7.87B29.8×5.6×22.8×3.2×13.5%0.1×0.78

Forecasts

5 strong buy · 1 buy · 6 hold · 1 strong sell · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
68.00 USD · Analysts' mean
EPS, year to Dec 2026
2.13 · 13 analysts
Revenue, year to Dec 2026
3.54B · 12 analysts

Team and board

Officers

OfficerRole
Joe KostkaInvestor Relations
Kevin CullenVP, Innovation and Economic Development
Jason SerinManager of Lab Equipment Maintenance
Nawaf AlgainManager of Tenant Affairs
Ohoud AlharbiExecutive Business Manager

Board

DirectorRole
Stefan LangDirector
Thierry BernardDirector

Events

Calls

CallWhenStatus
Bruker (NASDAQ:BRKR) Q3 2026 Earnings CallWed, Nov 04, 2026 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q2 2026 Earnings CallTue, Aug 04, 2026 · 9:00 AM ETReplay
Bruker (NASDAQ:BRKR) Q1 2026 Earnings CallWed, May 06, 2026 · 8:00 AM ETReplay
Bruker (NASDAQ:BRKR) Q4 2025 Earnings CallThu, Feb 12, 2026 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q3 2025 Earnings CallMon, Nov 03, 2025 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q2 2025 Earnings CallMon, Aug 04, 2025 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q1 2025 Earnings CallWed, May 07, 2025 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q4 2024 Earnings CallThu, Feb 13, 2025 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q3 2024 Earnings CallTue, Nov 05, 2024 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q1 2024 Earnings CallThu, May 02, 2024 · 8:30 AM ETReplay
All 25 calls
CallWhenStatus
Bruker (NASDAQ:BRKR) Q4 2023 Earnings CallTue, Feb 13, 2024 · 8:00 AM ETReplay
Bruker (NASDAQ:BRKR) Q3 2023 Earnings CallThu, Nov 02, 2023 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q2 2023 Earnings CallThu, Aug 03, 2023 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q1 2023 Earnings CallThu, May 04, 2023 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q4 2022 Earnings CallThu, Feb 09, 2023 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q3 2022 Earnings CallThu, Nov 03, 2022 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q2 2022 Earnings CallWed, Aug 03, 2022 · 4:30 PM ETReplay
Bruker (NASDAQ:BRKR) Q1 2022 Earnings CallWed, May 04, 2022 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q4 2021 Earnings CallFri, Feb 11, 2022 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q3 2021 Earnings CallMon, Nov 01, 2021 · 4:30 PM ETReplay
Bruker (NASDAQ:BRKR) Q2 2021 Earnings CallMon, Aug 02, 2021 · 4:30 PM ETReplay
Bruker (NASDAQ:BRKR) Q1 2021 Earnings CallWed, May 05, 2021 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q4 2020 Earnings CallTue, Feb 16, 2021 · 8:30 AM ETReplay
Bruker (NASDAQ:BRKR) Q3 2020 Earnings CallMon, Nov 02, 2020 · 4:30 PM ETReplay
Bruker (NASDAQ:BRKR) Q2 2020 Earnings CallMon, Aug 03, 2020 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 4, 2026 · Before open+12.9%
Q2 2026Aug 4, 2026 · Before open−21.8%
Q1 2026May 6, 2026 · Before open+11.3%
Q4 2025Feb 12, 2026 · Before open−11.6%
Q3 2025Nov 3, 2025 · Before open−0.6%
Q2 2025Aug 4, 2025 · Before open−8.6%
Q1 2025May 7, 2025 · Before open+3.3%
Q4 2024Feb 13, 2025 · Before open−1.0%
Q3 2024Nov 5, 2024 · Before open+3.4%
Q2 2024Aug 6, 2024 · Before open−2.2%
All 20 quarters
QuarterResultsShare move
Q1 2024May 2, 2024 · Before open−11.3%
Q4 2023Feb 13, 2024 · Before open+8.8%
Q3 2023Nov 2, 2023 · Before open−1.1%
Q2 2023Aug 3, 2023 · Before open−4.8%
Q1 2023May 4, 2023 · Before open+1.7%
Q4 2022Feb 9, 2023 · Before open+1.3%
Q3 2022Nov 3, 2022 · Before open+5.1%
Q2 2022Aug 3, 2022 · After close−7.1%
Q1 2022May 4, 2022 · Before open+6.3%
Q4 2021Feb 11, 2022 · Before open−4.5%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings17 slidesNov 4, 2026
Q2 2026 Earnings PresentationEarnings17 slidesAug 4, 2026
Q1 2026 Earnings PresentationEarnings16 slidesMay 6, 2026
Q4 2025 Earnings PresentationEarnings17 slidesFeb 12, 2026
J.P. Morgan 44th Annual Healthcare Conference 2026Conference22 slidesJan 12, 2026
Q3 2025 Earnings PresentationEarnings17 slidesNov 3, 2025
Q2 2025 Earnings PresentationEarnings17 slidesAug 4, 2025
Technical Presentation (June 2025)Technical37 slidesJun 26, 2025
Q1 2025 Earnings PresentationEarnings23 slidesMay 7, 2025
Q4 2024 Earnings PresentationEarnings32 slidesFeb 13, 2025
Show 50 decks
DeckKindSlidesDate
J.P. Morgan 43rd Annual Healthcare Conference 2025Conference20 slidesJan 13, 2025
Nasdaq 2024 London Investor ConferenceConference4 slidesDec 4, 2024
Q3 2024 Earnings PresentationEarnings34 slidesNov 5, 2024
Q2 2024 Earnings PresentationEarnings30 slidesAug 6, 2024
Investor Day (May 2024)Investor day48 slidesMay 17, 2024
Q1 2024 Earnings PresentationEarnings23 slidesMay 2, 2024
Q4 2023 Earnings PresentationEarnings33 slidesFeb 13, 2024
2024 J.P. Morgan Healthcare ConferenceConference25 slidesJan 8, 2024
Technical Presentation (November 2023)Technical56 slidesNov 2, 2023
Q3 2023 Earnings PresentationEarnings33 slidesNov 2, 2023
Q2 2023 Earnings PresentationEarnings33 slidesAug 3, 2023
Technical Presentation (June 2023)Technical11 slidesJun 28, 2023
Investor Day (June 2023)Investor day118 slidesJun 15, 2023
2023 Jefferies Healthcare ConferenceConference12 slidesJun 9, 2023
Q1 2023 Earnings PresentationEarnings24 slidesMay 4, 2023
Q4 2022 Earnings PresentationEarnings33 slidesFeb 9, 2023
2023 J.P. Morgan Healthcare ConferenceConference26 slidesJan 9, 2023
Technical Presentation (2023)Technical41 slides2023
Jefferies 2022 London Healthcare ConferenceConference12 slidesNov 15, 2022
Q3 2022 Earnings PresentationEarnings32 slidesNov 3, 2022
Q2 2022 Earnings PresentationEarnings32 slidesAug 3, 2022
Jefferies 2022 Global Healthcare ConferenceConference22 slidesJun 9, 2022
Q1 2022 Earnings PresentationEarnings24 slidesMay 4, 2022
Q4 2021 Earnings PresentationEarnings32 slidesFeb 11, 2022
40th Annual J.P. Morgan Healthcare Conference 2022Conference26 slidesJan 10, 2022
Q3 2021 Earnings PresentationEarnings30 slidesNov 1, 2021
Q2 2021 Earnings PresentationEarnings30 slidesAug 2, 2021
Investor Day (June 2021)Investor day100 slidesJun 17, 2021
Jefferies Virtual Healthcare Conference 2021Conference16 slidesJun 2, 2021
UBS Global Healthcare Virtual Conference 2021Conference15 slidesMay 24, 2021
BofA Securities 2021 Virtual Health Care ConferenceConference14 slidesMay 11, 2021
Q1 2021 Earnings PresentationEarnings21 slidesMay 5, 2021
Q4 2020 Earnings PresentationEarnings28 slidesFeb 16, 2021
39th Annual J.P. Morgan Healthcare Conference (January 2021)Conference24 slidesJan 11, 2021
Q3 2020 Earnings PresentationEarnings27 slidesNov 2, 2020
Q2 2020 Earnings PresentationEarnings28 slidesAug 3, 2020
Q1 2020 Earnings PresentationEarnings25 slidesMay 6, 2020
Q4 2019 Earnings PresentationEarnings23 slidesFeb 18, 2020
38th Annual JP Morgan Healthcare Conference 2020Conference28 slidesJan 13, 2020
Stifel 2019 Healthcare ConferenceConference22 slidesNov 19, 2019

This page holds 50 of 105 decks. Open Decks

Open Decks

Financings

RaiseDate
Public offering of 6.375% Mandatory Convertible Preferred Stock, Series A
Update: US$600M · J.P. Morgan +2
Dealers: J.P. Morgan (co-lead), BofA Securities (co-lead), PNC Capital Markets LLC
Use of proceeds: Repay the term loan due December 2026 in full, revolving credit borrowings in full, and part of the term loan due March 2027
Sep 3, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue3.44B3.37B2.96B2.53B2.42B1.99B2.07B1.90B1.77B1.61B
Cost of revenue1.86B1.72B1.45B1.23B1.21B1.05B1.08B995.6M949.9M866.0M
Gross profit1.58B1.65B1.51B1.31B1.21B939.8M995.3M900.0M816.0M745.3M
Research and development395.2M376.5M294.8M235.9M220.8M198.0M187.7M173.4M161.6M147.9M
Selling, general and administrative946.5M893.8M729.4M607.4M561.2M468.6M500.2M444.7M415.2M389.8M
Operating income68.2M253.1M436.9M432.7M413.3M248.3M300.9M262.4M219.5M181.8M
Depreciation and amortization220.3M183.8M114.9M88.8M89.1M80.4M75.6M64.9M63.9M54.3M
EBITDA288.5M436.9M551.8M521.5M502.4M328.7M376.5M327.3M283.4M236.1M
Interest expense60.3M47.9M16.4M16.1M14.3M14.4M16.0M12.6M15.4M13.2M
Income before tax22.0M206.9M544.2M413.9M393.6M225.8M280.4M244.7M197.8M177.6M
Income tax29.3M91.4M117.7M116.4M113.0M64.4M82.4M63.7M117.5M23.1M
Net income-8.60M113.1M427.2M296.6M277.1M157.8M197.2M179.7M78.6M153.6M
Earnings per share, basic-0.150.762.922.001.831.031.271.150.500.95
Earnings per share, diluted-0.150.762.901.991.811.021.261.140.490.95

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents298.8M183.4M488.3M645.5M1.07B681.8M678.3M322.4M325.0M342.4M
Short-term investments12.0M0100.0M50.0M6.60M0114.2M157.9M
Receivables544.9M565.5M492.0M472.7M416.9M335.3M362.2M357.2M319.3M243.9M
Inventory1.09B1.07B968.3M800.1M710.1M692.3M577.2M509.6M486.2M440.4M
Current assets2.21B2.05B2.16B2.11B2.47B1.93B1.80B1.30B1.36B1.28B
Property, plant and equipment744.8M669.3M599.7M487.0M406.1M395.5M306.1M270.6M266.5M239.1M
Goodwill1.55B1.51B582.6M457.6M339.5M320.4M293.0M275.7M169.8M130.6M
Total assets6.24B5.81B4.25B3.61B3.65B3.05B2.77B2.13B1.95B1.81B
Accounts payable215.9M234.1M202.7M178.4M147.4M134.6M118.4M104.5M90.8M86.1M
Current liabilities1.28B1.28B1.20B914.3M938.5M791.9M645.6M599.3M524.5M524.7M
Long-term debt1.85B2.06B1.16B1.20B1.22B842.3M812.8M322.6M415.6M391.6M
Total debt1.87B2.09B1.28B1.22B1.33B844.5M813.3M341.1M415.6M411.7M
Total liabilities3.73B3.99B2.84B2.48B2.57B2.07B1.83B1.22B1.22B1.12B
Shareholders' equity2.46B1.78B1.38B1.11B1.07B961.2M906.8M896.6M725.4M686.4M
Shares outstanding152.1M151.7M145.2M147.0M150.8M152.0M154.2M156.6M155.9M159.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations134.1M251.3M350.1M274.4M282.4M332.2M213.4M239.7M154.4M130.8M
Capital spending-90.8M-115.3M-106.9M-129.2M-92.0M-97.2M-73.0M-49.2M-43.7M-37.1M
Free cash flow43.3M136.0M243.2M145.2M190.4M235.0M140.4M190.5M110.7M93.7M
Cash from investing-196.5M-1.76B-326.0M-251.6M-192.4M-192.7M-158.4M-123.4M-30.2M-21.8M
Cash from financing135.1M1.23B-193.4M-415.3M318.7M-161.6M300.0M-112.4M-159.0M-27.9M
Dividends paid-22.8M-30.2M-29.4M-29.8M-24.2M-24.6M-25.0M-25.1M-25.4M-25.8M
Share buybacks-10.0M0-152.3M-263.1M-153.3M-123.2M-142.3M-152.2M-152.2M-160.0M
Change in cash116.4M-304.9M-157.1M-423.0M386.2M3.60M355.6M-2.60M-17.0M74.7M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 16, 2026Management or board changeSEC
8-K · Current reportNov 5, 2026Current reportSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 4, 2026ResultsSEC
8-K · Current reportOct 29, 2026Current reportSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
144 · Notice of proposed saleSep 15, 2026Other filingsSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
144 · Notice of proposed saleAug 17, 2026Other filingsSEC
144 · Notice of proposed saleAug 14, 2026Other filingsSEC
8-K · Current reportAug 14, 2026Current reportSEC
4 · Change in ownershipAug 13, 2026Insider tradeSEC
4 · Change in ownershipAug 13, 2026Insider tradeSEC
4 · Change in ownershipAug 13, 2026Insider tradeSEC
4 · Change in ownershipAug 11, 2026Insider tradeSEC
4 · Change in ownershipAug 11, 2026Insider tradeSEC
4 · Change in ownershipAug 11, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 6, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 5, 2026Quarterly reportSEC
8-K · Current reportAug 4, 2026ResultsSEC
8-K · Current reportJul 30, 2026Current reportSEC
4 · Change in ownershipJul 16, 2026Insider tradeSEC
144 · Notice of proposed saleJul 15, 2026Other filingsSEC
3 · Initial statement of ownershipJul 10, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
S-3ASR · Registration statementJun 12, 2026Offer documentSEC
SD · Specialized disclosureMay 29, 2026ESG reportSEC
8-K/A · Current report, amendedMay 29, 2026Meeting outcomeSEC
8-K · Current reportMay 21, 2026Meeting outcomeSEC
4 · Change in ownershipMay 19, 2026Insider tradeSEC
4 · Change in ownershipMay 18, 2026Insider tradeSEC
8-K · Current reportMay 15, 2026Current reportSEC
144 · Notice of proposed saleMay 15, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 6, 2026Big-stake noticeSEC
8-K · Current reportMay 6, 2026ResultsSEC
8-K · Current reportApr 28, 2026Current reportSEC
4 · Change in ownershipApr 16, 2026Insider tradeSEC
144 · Notice of proposed saleApr 15, 2026Other filingsSEC
ARS · Annual report to shareholdersApr 10, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 10, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 10, 2026Meeting noticeSEC
3 · Initial statement of ownershipApr 10, 2026Insider tradeSEC
8-K · Current reportApr 10, 2026Management or board changeSEC
8-K · Current reportApr 1, 2026Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
144 · Notice of proposed saleMar 13, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 6, 2026Big-stake noticeSEC
S-8 POSFeb 27, 2026Offer documentSEC
S-8 · Registration statement for employee plansFeb 27, 2026Offer documentSEC
10-K · Annual reportFeb 27, 2026Annual reportSEC
8-K · Current reportFeb 20, 2026Management or board changeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
144 · Notice of proposed saleFeb 13, 2026Other filingsSEC
8-K · Current reportFeb 12, 2026ResultsSEC
4 · Change in ownershipJan 16, 2026Insider tradeSEC
144 · Notice of proposed saleJan 15, 2026Other filingsSEC
4 · Change in ownershipJan 13, 2026Insider tradeSEC
144 · Notice of proposed saleJan 12, 2026Other filingsSEC
8-K · Current reportJan 12, 2026ResultsSEC
3 · Initial statement of ownershipJan 9, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
144 · Notice of proposed saleJan 5, 2026Other filingsSEC
8-K · Current reportDec 9, 2025Management or board changeSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
144 · Notice of proposed saleDec 1, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
4 · Change in ownershipNov 10, 2025Insider tradeSEC
144 · Notice of proposed saleNov 6, 2025Other filingsSEC
10-Q · Quarterly reportNov 5, 2025Quarterly reportSEC
8-K · Current reportNov 3, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 7, 2025Big-stake noticeSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
144 · Notice of proposed saleSep 12, 2025Other filingsSEC
CERT · Exchange's certificate of listingSep 8, 2025Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeSep 8, 2025Other filingsSEC
8-K · Current reportSep 8, 2025Current reportSEC
424B5 · ProspectusSep 5, 2025Offer documentSEC
FWP · Free writing prospectusSep 4, 2025Offer documentSEC
424B5 · ProspectusSep 2, 2025Offer documentSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 7, 2025Insider tradeSEC
4 · Change in ownershipAug 7, 2025Insider tradeSEC
4 · Change in ownershipAug 7, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 6, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 5, 2025Quarterly reportSEC
8-K · Current reportAug 4, 2025ResultsSEC
8-K · Current reportJul 21, 2025ResultsSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
SD · Specialized disclosureMay 30, 2025ESG reportSEC
8-K · Current reportMay 29, 2025Management or board changeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
DEFA14A · Additional proxy materialMay 19, 2025Meeting noticeSEC
4 · Change in ownershipMay 14, 2025Insider tradeSEC
8-K · Current reportMay 14, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 12, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 7, 2025Quarterly reportSEC
8-K · Current reportMay 7, 2025ResultsSEC
4 · Change in ownershipApr 24, 2025Insider tradeSEC
ARS · Annual report to shareholdersApr 11, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 11, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 11, 2025Meeting noticeSEC
8-K · Current reportApr 11, 2025ResultsSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
10-K · Annual reportMar 3, 2025Annual reportSEC
8-K · Current reportFeb 21, 2025Management or board changeSEC
3 · Initial statement of ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
8-K · Current reportFeb 13, 2025ResultsSEC
3 · Initial statement of ownershipJan 16, 2025Insider tradeSEC
8-K · Current reportJan 16, 2025Management or board changeSEC
8-K · Current reportJan 13, 2025ResultsSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
144 · Notice of proposed saleDec 2, 2024Other filingsSEC
4 · Change in ownershipNov 25, 2024Insider tradeSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
8-K · Current reportNov 5, 2024ResultsSEC
4 · Change in ownershipAug 16, 2024Insider tradeSEC
144 · Notice of proposed saleAug 15, 2024Other filingsSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
10-Q · Quarterly reportAug 9, 2024Quarterly reportSEC
4 · Change in ownershipAug 7, 2024Insider tradeSEC
4 · Change in ownershipAug 7, 2024Insider tradeSEC
4 · Change in ownershipAug 7, 2024Insider tradeSEC
8-K · Current reportAug 7, 2024Management or board changeSEC
8-K · Current reportAug 6, 2024ResultsSEC
8-K/A · Current report, amendedJun 5, 2024Material contractSEC
8-K · Current reportMay 31, 2024Material contractSEC
424B5 · ProspectusMay 30, 2024Offer documentSEC
8-K · Current reportMay 30, 2024Meeting outcomeSEC
S-3ASR · Registration statementMay 29, 2024Offer documentSEC
SD · Specialized disclosureMay 23, 2024ESG reportSEC
ARS · Annual report to shareholdersMay 15, 2024Annual reportSEC
10-Q · Quarterly reportMay 10, 2024Quarterly reportSEC
8-K · Current reportMay 2, 2024ResultsSEC
8-K · Current reportMay 2, 2024Current reportSEC
8-K · Current reportApr 22, 2024Material contractSEC
DEFA14A · Additional proxy materialApr 19, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 19, 2024Meeting noticeSEC
8-K · Current reportApr 2, 2024Material contractSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 6, 2024Insider tradeSEC
144 · Notice of proposed saleMar 4, 2024Other filingsSEC
4 · Change in ownershipMar 1, 2024Insider tradeSEC
10-K · Annual reportFeb 29, 2024Annual reportSEC
144 · Notice of proposed saleFeb 28, 2024Other filingsSEC
4 · Change in ownershipFeb 26, 2024Insider tradeSEC
144 · Notice of proposed saleFeb 22, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Bruker Corporation’s releases

Common shares
152,722,385
Fully diluted
152,722,385

Fully diluted

LineShares
Common shares152,722,385

Share count over time

CountShares
Nov 22, 2026152,722,385

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Fidelity20.7M13.6%US$1.52BSep 30, 2026
Orbis Allan Gray Ltd17.9M11.7%US$1.16BSep 30, 2026
BlackRock12M7.8%US$842MSep 30, 2026
Vanguard10.7M7.0%US$695MSep 30, 2026
Pallas Capital Advisors LLC9.48M6.2%US$614MSep 30, 2026
State Street4.04M2.6%US$275MSep 30, 2026
T. Rowe Price3.69M2.4%US$239MSep 30, 2026
AQR Capital Management LLC3.07M2.0%US$199MSep 30, 2026
Sculptor Capital LP3.02M2.0%US$203MSep 30, 2026
Edmond De Rothschild Holding S.A.2.65M1.7%US$171MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Dimensional2.58M1.7%US$167MSep 30, 2026
Franklin Templeton2.39M1.6%US$233MSep 30, 2026
Geode Capital2.24M1.5%US$145MSep 30, 2026
Alyeska Investment Group, L.P.1.96M1.3%US$127MSep 30, 2026
Morgan Stanley1.79M1.2%US$127MSep 30, 2026
Artisan Partners Limited Partnership1.67M1.1%US$108MSep 30, 2026
First Trust1.52M1.00%US$98.5MSep 30, 2026
Schwab1.5M0.98%US$97.2MSep 30, 2026
Snyder Capital Management L P1.44M0.95%US$93.6MSep 30, 2026
Glenview Capital Management, LLC1.38M0.90%US$89.2MSep 30, 2026
Freestone Grove Partners LP1.18M0.77%US$76.3MSep 30, 2026
Barrow Hanley Mewhinney & Strauss LLC1.01M0.66%US$65.7MSep 30, 2026
Jennison Associates LLC1M0.66%US$64.9MSep 30, 2026
Northern Trust982K0.64%US$63.6MSep 30, 2026
Brown Advisory Inc971K0.64%US$62.9MSep 30, 2026
Primecap Management Co970K0.64%US$62.8MSep 30, 2026
Bank of America912K0.60%US$64.1MSep 30, 2026
UBS802K0.53%US$52.1MSep 30, 2026
Royal London Asset Management LTD781K0.51%US$50.6MSep 30, 2026
BNY774K0.51%US$50.1MSep 30, 2026
Old West Investment Management, LLC664K0.43%US$43MSep 30, 2026
Goldman Sachs610K0.40%US$39.5MSep 30, 2026
Anomaly Capital Management, LP587K0.38%US$38MSep 30, 2026
Aequim Alternative Investments LP580K0.38%US$275MSep 30, 2026
Voloridge Investment Management, LLC511K0.33%US$33.1MSep 30, 2026
BNP Paribas500K0.33%US$32.4MSep 30, 2026
Bridgewater Associates, LP488K0.32%US$31.6MSep 30, 2026
Grantham, Mayo, Van Otterloo & Co. LLC461K0.30%US$29.8MSep 30, 2026
Gotham Asset Management, LLC458K0.30%US$29.7MSep 30, 2026
Nomura451K0.30%US$29.2MSep 30, 2026
Steadfast Capital Management LP429K0.28%US$27.8MSep 30, 2026
M&G PLC426K0.28%US$27.7MSep 30, 2026
Becker Capital Management Inc418K0.27%US$27.1MSep 30, 2026
Candriam S.C.A.415K0.27%US$27MSep 30, 2026
JPMorgan404K0.26%US$35.3MSep 30, 2026
Marshall Wace, LLP401K0.26%US$26MSep 30, 2026
Barclays377K0.25%US$24.4MSep 30, 2026
D. E. Shaw & Co., Inc.371K0.24%US$120MSep 30, 2026
Susquehanna357K0.23%US$23.4MSep 30, 2026
Needham Investment Management LLC355K0.23%US$23MSep 30, 2026

This page holds 50 of 437 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
iShares Core S&P Mid-Cap ETF3.8M2.5%US$229MJun 30, 2026
Vanguard Total Stock Market Index Fund3.38M2.2%US$203MJun 30, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund2.73M1.8%US$161MMay 31, 2026
Vanguard Small-Cap Index Fund2.44M1.6%US$147MJun 30, 2026
Fidelity Series Large Cap Stock Fund2.36M1.5%US$142MJun 30, 2026
First Trust NYSE Arca Biotechnology Index Fund2.02M1.3%US$122MJun 30, 2026
Touchstone Funds Group Trust-Touchstone Mid Cap Fund1.92M1.3%US$116MJun 30, 2026
T. Rowe Price All-Cap Opportunities Fund1.76M1.2%US$106MJun 30, 2026
Vanguard Small-Cap Value Index Fund1.55M1.0%US$93.2MJun 30, 2026
Franklin Small Cap Value Fund1.42M0.93%US$89.2MJul 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund1.28M0.83%US$76.7MJun 30, 2026
Fidelity Dividend Growth Fund1.22M0.80%US$77MJul 31, 2026
Fidelity Mid-Cap Stock Fund894K0.59%US$56.2MJul 31, 2026
Fidelity Large Cap Stock Fund887K0.58%US$55.7MJul 31, 2026
Select Health Care Portfolio850K0.56%US$50.1MMay 31, 2026
iShares Biotechnology ETF788K0.52%US$47.4MJun 30, 2026
Select Medical Technology and Devices Portfolio760K0.50%US$44.8MMay 31, 2026
Vanguard Capital Opportunity Fund730K0.48%US$43.9MJun 30, 2026
Fidelity Growth and Income Portfolio686K0.45%US$43.1MJul 31, 2026
Fidelity Capital Appreciation Fund623K0.41%US$39.1MJul 31, 2026
Franklin Small Cap Value VIP Fund582K0.38%US$35.1MJun 30, 2026
U.S. Small Cap Portfolio578K0.38%US$36.3MJul 31, 2026
Fidelity Extended Market Index Fund570K0.37%US$33.6MMay 31, 2026
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF562K0.37%US$33.8MJun 30, 2026
Schwab U.S. Small-Cap ETF533K0.35%US$31.4MMay 31, 2026
Fidelity Advisor Capital Development Fund506K0.33%US$30.5MJun 30, 2026
Dimensional U.S. Small Cap ETF487K0.32%US$30.6MJul 31, 2026
BlackRock Health Sciences Opportunities Portfolio472K0.31%US$27.8MMay 29, 2026
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF459K0.30%US$27.6MJun 30, 2026
Fidelity Advisor Health Care Fund457K0.30%US$28.7MJul 31, 2026
iShares Russell Mid-Cap ETF455K0.30%US$27.4MJun 30, 2026
Fidelity Mid Cap Index Fund420K0.28%US$26.4MJul 31, 2026
Nomura Small Cap Value Fund416K0.27%US$24.5MMay 29, 2026
Artisan Small Cap Fund386K0.25%US$23.2MJun 30, 2026
iShares S&P Mid-Cap 400 Growth ETF354K0.23%US$21.3MJun 30, 2026
Fidelity U.S. Equity Central Fund345K0.23%US$20.8MJun 30, 2026
Vanguard Health Care Index Fund320K0.21%US$18.9MMay 31, 2026
Needham Aggressive Growth Fund311K0.20%US$18.7MJun 30, 2026
Schwab Fundamental U.S. Small Company ETF308K0.20%US$18.1MMay 31, 2026
Schwab U.S. Mid-Cap ETF300K0.20%US$17.6MMay 31, 2026
AQR Long-Short Equity Fund291K0.19%US$17.5MJun 30, 2026
Dimensional U.S. Core Equity 2 ETF279K0.18%US$17.5MJul 31, 2026
iShares S&P Mid-Cap 400 Value ETF262K0.17%US$15.7MJun 30, 2026
iShares Russell 1000 Value ETF248K0.16%US$14.9MJun 30, 2026
Brown Advisory Small-Cap Growth Fund223K0.15%US$13.4MJun 30, 2026
Nomura VIP Small Cap Value Series217K0.14%US$13.1MJun 30, 2026
GMO Small Cap Quality Fund213K0.14%US$12.5MMay 31, 2026
U.S. Core Equity 1 Portfolio212K0.14%US$13.3MJul 31, 2026
Fidelity Total Market Index Fund209K0.14%US$12.3MMay 31, 2026
U.S. Core Equity 2 Portfolio206K0.14%US$13MJul 31, 2026

This page holds 50 of 343 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Munch Mark
Officer: EXEC VP&PRES BRUKER NANO INC.
Sale2,000USD 52.87US$106KSep 15, 2026
Pusch Wolfgang
Officer: President BMID Group
Sale3,473USD 56.90US$198KAug 17, 2026
Munch Mark
Officer: EXEC VP&PRES BRUKER NANO INC.
Sale2,000USD 57.60US$115KAug 14, 2026
Munch Mark
Officer: EXEC VP&PRES BRUKER NANO INC.
Sale2,000USD 60.25US$121KJul 15, 2026
Munch Mark
Officer: EXEC VP&PRES BRUKER NANO INC.
Sale2,000USD 54.76US$110KJun 15, 2026
Munch Mark
Officer: EXEC VP&PRES BRUKER NANO INC.
Sale2,000USD 43.90US$87,800May 15, 2026
Munch Mark
Officer: EXEC VP&PRES BRUKER NANO INC.
Sale2,000USD 39.90US$79,800Apr 15, 2026

Big stakes

StakeStakeSharesDateFiling
FMR LLC15.00%23.3MJun 30, 2026Schedule 13G
ORBIS INVESTMENT MANAGEMENT LTD11.10%16.9MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Laura Francis
Other companies: SI-BONE, Inc. (Chief Executive Officer · Since at least Oct 16, 2018); Shockwave Medical Inc (Director · Mar 6, 2019 – May 31, 2024 · Past)
Director · Since at least Feb 18, 2025
Bonnie H Anderson
Other companies: Veracyte, Inc. (Director · May 1, 2022 – Jun 2, 2023 · Past)
Director · Since at least Jan 5, 2023
Jack Phillips
Other companies: Accelerate Diagnostics Inc (Chief Executive Officer, Director · Aug 6, 2019 – Apr 4, 2025 · Past)
Director · Since at least Jan 1, 2026
Joe Kostka
Other companies: SI-BONE, Inc. (Director, Investor Relations · Feb 21, 2025 – Nov 4, 2026 · Past)
Investor Relations · Since at least Dec 10, 2025
John A Ornell
Other companies: Waters Corporation (CFO · Aug 6, 2010 – Dec 6, 2013 · Past)
Director · Since at least Aug 19, 2015
Richard A Packer
Other companies: Teleflex Incorporated (Director · May 7, 2019 – May 4, 2021 · Past)
Director · Since at least Dec 16, 2019
Thomas Bures
Other companies: Palvella Therapeutics, Inc. (Chief Financial Officer · Sep 3, 2019 – Feb 24, 2023 · Past)
Chief Accounting Officer · Since at least Jan 13, 2025
Adelene Q PerkinsDirector · Since at least Jan 5, 2024
Burkhard PrausePRES. & CEO, BRUKER BEST · Since at least Mar 7, 2012
Cynthia M FriendDirector · Since at least May 20, 2016
All 29 people
PersonSeat
Dirk D LaukienDirector · Feb 12, 2007 – Mar 14, 2011 · Past
Frank H LaukienPRESIDENT & CEO, Director · Since at least Oct 26, 2023
Gerald N HermanEXECUTIVE VICE PRESIDENT, CFO · Since at least Aug 11, 2022
Hermann Fritz RequardtDirector · Since at least Feb 15, 2026
Jason SerinManager of Lab Equipment Maintenance · Since at least Nov 4, 2026
Juergen SregaPRESIDENT CALID · Since at least Aug 5, 2021
Kevin CullenVP, Innovation and Economic Development · Since at least Nov 4, 2026
Marc A KastnerDirector · Feb 12, 2013 – May 19, 2023 · Past
Mark MunchEXEC VP&PRES BRUKER NANO INC. · Since at least Aug 5, 2022
Nawaf AlgainManager of Tenant Affairs · Since at least Nov 4, 2026
Ohoud AlharbiExecutive Business Manager · Since at least Nov 4, 2026
Richard KnissDirector · Jan 5, 2017 – Jan 5, 2018 · Past
Stefan LangDirector · Since at least Jan 9, 2026
Stephan WestermannEVP-OEP&L · Mar 7, 2012 – Mar 7, 2012 · Past
Thierry BernardDirector · Since at least Apr 1, 2026
William A LintonDirector · Since at least Jan 5, 2011
William J KnightCOO/Interim CFO · Jan 5, 2006 – Sep 9, 2011 · Past
Wolf-Dieter EmmerichDirector · Jan 5, 2011 – May 12, 2016 · Past
Wolfgang PuschPresident BMID Group · Since at least Jul 1, 2026

Open People

Log in to ask 6ix AI your own questions about Bruker Corporation.